3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Solid Tumors
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Leukemia, Plasma Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Monocytic, Acute
1
Hodgkin Disease
1
Burkitt Lymphoma
1
Adenocarcinoma, Bronchiolo-Alveolar
1
Adenocarcinoma of Lung
1
Interventions
fludarabine
17
Cyclophosphamide
15
Specimen Handling
14
Biopsy
12
fludarabine phosphate
11
Melphalan
10
Cytarabine
10
Busulfan
10
Mycophenolic Acid
9
Whole-Body Irradiation
8
Tacrolimus
8
venetoclax
7
decitabine and cedazuridine drug combination
7
Granulocyte Colony-Stimulating Factor
7
Injections
6
Cyclosporine
6
Stem Cell Transplantation
5
Sirolimus
5
Filgrastim
5
Azacitidine
5
X-Rays
4
Thiotepa
4
Peripheral Blood Stem Cell Transplantation
4
Idarubicin
4
CPX-351
4
ruxolitinib
3
Magnetic Resonance Spectroscopy
3
Hematopoietic Stem Cell Transplantation
3
Decitabine
3
treosulfan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
pegylated granulocyte colony-stimulating factor
×
30 days
×
Clear all
No trials found.